Vertiv Holdings Co (VRT): what the price requires

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/VRT

Headline

Field	Value
Ticker	VRT
Company	Vertiv Holdings Co
Current price	$306.11/sh
Composition	Products 80% / Services & spares 20%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin today	16.9%
Must persist for	23.3y
Multiple paid	70x operating income

Solve inputs: computed at a 14.1% cost of capital; growth searched up to the 26% self-funding ceiling; each 1pp moves the implied horizon ~3.1 years.

Reconcile: at the x-ray's 9.3% required return this reads ~11.7 years; the models below use their own rates.

How unusual the bet is: high

Reference	Value
vs own history	-0.36σ
cohort percentile (of 177 peers)	93
sustained it ~10 years at this level	13%
implied end-window share	2%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	5.84x	4	expensive
Earnings	5.16x	5	expensive
Relative	2.21x	5	expensive
Growth	0.87x	3	justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.

Per-Model Detail (n=17)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$249.96	1.22x	yes	FCF base $2.5B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.0%, 7yr projection
DCF Exit Multiple	Growth	$352.17	0.87x	yes	Exit EV/EBITDA: 50.0x / 52.0x / 54.0x (bear / base = today's held flat / bull), 7yr
Relative Valuation	Relative	$170.18	1.80x	yes	P/E 38.51x (blended: static sector reference 22x + trailing (TTM) 77x), scenarios: 30.8x / 38.5x / 46.2x (bear / base = reference held flat / bull), EV/EBITDA 26.8x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$42.96	7.13x	yes	BV/sh $10.83, ROE (TTM) 36.7%, ke 9.3%
Two-Stage Excess Return	Asset	$92.62	3.30x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$436.03	0.70x	yes	Rev $10.8B, growth 29% (input: historical growth; tapered), Terminal P/S: 8.9x / 11.1x / 13.3x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair Value	Relative	$47.76	6.41x	yes	EPS $3.98, growth 1% (input: historical EPS growth), PEG=57.28 (Overvalued)
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$23.02	13.30x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $1.00B × (1−11%) / WACC 9.0% → EPV (no growth)
Residual Income	Asset	$67.35	4.54x	yes	BV $10.83 + 5yr PV of (ROE (TTM) 36.7% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham Number	Asset	$31.14	9.83x	yes	√(22.5 × EPS $3.98 × BVPS $10.83) — Graham's conservative floor
EV/EBITDA Relative	Relative	$92.67	3.30x	yes	EBITDA $2.32B × sector EV/EBITDA 16.0x
FCF Yield	Earnings	$60.74	5.04x	yes	FCF $2281.2M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$59.31	5.16x	yes	SBC-adj FCF $2.23B (FCF $2.28B − SBC $0.05B) capitalized at Kₑ
Ben Graham Formula	Earnings	$128.42	2.38x	yes	EPS $3.98 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/B	Asset	$9.23	33.16x	yes	BV $10.83 × (ROIC 7.7% / WACC 9.0%) (excluded from median)
P/Sales Sector	Relative	$138.26	2.21x	yes	Revenue $10.84B × sector P/S 5.0x
PEG Fair Value	Relative	$149.25	2.05x	yes	EPS $3.98 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings Yield	Earnings	$43.03	7.11x	yes	EPS $3.98 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$771.6m
Net debt / NOPAT (after-tax)	0.51x
Net debt / operating income (pre-tax)	0.46x
Interest coverage	26.0x
Share count CAGR (dilution)	0.8%
Burning cash	no

Bullet Takeaways

• Vertiv sells the picks and shovels of the AI buildout, the power and cooling gear that sits between the utility and the chip, and its order backlog roughly doubled to about $15.0 billion at year-end 2025 from $7.2 billion a year earlier.
• The biggest risk is durability of pace rather than the pace itself: at today's price the market is paying roughly 76 times operating income, a level only the most aggressive growth method reaches, and the 10-K already warns that its largest customers "may require more favorable terms" on the multi-year AI projects driving the boom.
• Watch order intake on each quarterly print, the single number that signals whether hyperscaler demand is still accelerating; management raised full-year 2026 sales guidance to $13.5 to $14.0 billion alongside Q1 results.

Bull Case

Start with what the price is paying for, then check it against what the business has shown. At $333 the market values Vertiv at roughly 76 times company-wide operating income, a multiple that sits at the very top of its peer group and well past the upper quartile. That is a steep number for an industrial. The question is whether the underlying business has earned the benefit of the doubt, and on the evidence it has come closer than the multiple alone suggests.

Vertiv builds the power and thermal infrastructure that keeps data centers running, and the AI compute wave has turned that from a steady industrial line into a genuine demand surge. The clearest evidence is the order book. The FY2025 10-K reports estimated combined order backlog of "approximately $15.0 billion and $7.2 billion" at the end of 2025 and 2024 respectively, an order base that roughly doubled in a single year. The filing ties the surge directly to the AI cycle, describing capacity additions "to support additional demand for AI infrastructure as necessary" and continued investment "to support additional growth driven by AI." Backlog of this size, against a roughly $10.8 billion revenue base, is forward revenue the company has already won rather than hopes to.

The economics underneath are strong for an equipment maker. Returns on equity run in the mid-30s on a trailing basis, interest coverage sits above 35 times, and net debt is under half a year of operating income, so the balance sheet carries the growth rather than strains under it. The geographic mix shows where the money is made. The Americas, the heart of the hyperscaler buildout, throw off a 26.7% operating margin on 58% of sales, far above the high-single-digit margin in Asia Pacific. As that region's share of the order book grows, blended margin has room to follow. The recurring services and spares line, a fifth of the business, attaches to an installed base that only expands as more boxes ship. Vertiv is not betting on inventing the AI demand. It supplies the physical bottleneck the demand has to pass through, and the order book says the customers have already committed.

Bear Case

The harder questions sit on the customer side of the contract. Vertiv's order surge is concentrated in a small set of very large buyers, and the 10-K is candid that this concentration cuts both ways. The filing warns of customers' "purchasing leverage and, consequently, increasing the product pricing pressures facing our business," and that "consolidation or reduction in technology spend could lead to a significant decline in business with, or pricing pressure from, one or more of our key customers." More pointedly, it notes those customers "may require more favorable terms and conditions in their contracts with us, including in connection with large, multi-year projects to support artificial intelligence and other high-density compute workloads," and may impose substantial penalties for product or service failures. The same hyperscaler concentration that fills the backlog is the lever that can squeeze the margin out of it.

Then there is what the price requires. Today's roughly 76 times operating income implies company-wide operating growth holds near its self-funding ceiling for something like twenty-four years. The near-term pace is within reach of what Vertiv has recently delivered; the stretch is in how long it must persist. History is not kind to that kind of duration. Of comparable fast-growers, only about 13% sustained this pace for even a decade. Strip the growth assumption and the static frames land far below the price. The asset-value and earnings-power methods cluster at a small fraction of $333, and only the growth-extrapolating methods reach it. If AI capex digestion arrives, or the buildout simply normalizes after the first wave, the multiple has a long way to compress before it meets the methods that do not assume the boom continues.

Capital allocation rounds out the caution. Vertiv runs net debt rather than net cash, and its share count has crept up at a low-single-digit pace rather than fallen, so holders are funding the growth through modest dilution rather than receiving buyback support at this valuation. That is a defensible choice for a company investing into a demand wave, with a roughly $50 million expansion of its Ohio liquid-cooling capacity among the projects underway. But it means the bull case rests entirely on the order book converting and the margins holding, with no balance-sheet cushion of returned cash to fall back on if the cycle turns.

Valuation

The price is making one specific bet. At $333 the market pays roughly 76 times company-wide operating income, which works out to operating growth held near its self-funding ceiling for about twenty-four years. Keep those figures approximate; they come from a single backward solve. The point is the shape of the bet, not the decimal: this is a long-duration compounding wager, not a cheap stock.

The methods we use to triangulate split cleanly, and the split is the information. The asset-value lens, book value plus excess returns, and the earnings-power lens, normalized operating earnings capitalized at the cost of capital, both land far below the price, in the $20s to low $90s per share. Peer-multiple methods reach the $130s to $180s. Only the forward-growth methods reach $333, and one of them, the exit-multiple DCF, gets there by holding today's roughly 55 times EV/EBITDA flat for the life of the forecast. When every static frame says richly valued and only the growth extrapolation reaches the price, the premium is paying for durable compounding the standard methods structurally cannot frame. That is a moat-and-durability bet, priced as if it is already settled.

The balance sheet can carry it. Net debt sits under half a year of operating profit, interest coverage runs above 35 times, and the company is not burning cash. Against the prior-year base, the 10-K notes FY2024 net sales of "$8,011.8", which against the larger 2025 figure shows how fast the top line has moved. The downside floor is solid. The open question sits entirely on the upside side of the ledger, where the price already assumes the order book keeps compounding for two decades.

Catalysts

Vertiv used its Q1 2026 print to lift the bar. The company reported first-quarter net sales of about $2.65 billion with net income near $390 million, and raised full-year 2026 net sales guidance to a range of $13.5 to $14.0 billion, with full-year adjusted EPS guidance moved up to $6.30 to $6.40, ahead of the prior consensus near $6.08. Management tied the raise to AI-driven data-center demand and a project backlog it described as above $15.0 billion, covering roughly twelve to eighteen months of forward revenue.

Analyst sentiment has tracked the fundamentals. The stock carries a Buy consensus, with Oppenheimer raising its target to $353 from $330 at an Outperform rating and Bernstein initiating at Outperform with a $416 target; the average target sits in the high $300s with a wide spread from the $260s to $500. The watch items are concrete. Each quarter's order intake is the cleanest read on whether the AI buildout is still accelerating, and the roughly $50 million Ohio expansion lifting liquid-cooling capacity at Ironton by about 45% is the supply-side signal that management expects the demand to persist. The competitive set, Eaton, Schneider Electric, and nVent among them, is investing into the same wave, so the order conversion rate matters more than the headline backlog.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• ETN (EATON CORPORATION plc)
• (no filing in the citation store)
• NVT (nVent Electric plc)
• (no filing in the citation store)
• HUBB (HUBBELL INC)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, reported May 2026 · analyst notes, June 2026 · company facility announcement, 2026